Equity Research, Broker Reports, and media content on Shield Therapeutics Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Shield Therapeutics Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Shield Therapeutics Plc

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Shield Therapeutics Plc. We currently have 411 research reports from 9 professional analysts.

  • Open: 6.15p
  • Range Today: 6.01/6.14p
  • 52 Week: 5.72/12.8p
  • Daily Volume: 1.1m
  • Daily Liquidity: 0.14%
  • # Shares: 782.1m
  • Market Cap: £48.1m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
27Nov23 17:24 RNS Shield Therapeutics - PDMR Transaction Notification
15Nov23 07:30 DGAP-News Hardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team
20Oct23 11:45 RNS Shield Therapeutics - Abstract to be presented at Healthcare Conference
12Oct23 07:00 RNS Shield Therapeutics - Chief Financial Officer Transition
03Oct23 15:00 RNS Shield Therapeutics - Result of REX Retail Offer
03Oct23 07:00 RNS Shield Therapeutics - Block listing Interim Return
03Oct23 07:00 RNS Shield Therapeutics - Completion of SWK Financing
  • Frequency of research reports


  • Research reports on

    Shield Therapeutics Plc

  • Providers covering

    Shield Therapeutics Plc